Review Article
Role of NEK2A in Human Cancer and Its Therapeutic Potentials
Table 2
Aberrant expression of NEK2A in different cancers.
| Cancer type | NEK2A upregulation | Detect method | Reference number |
| Ewing tumor | Cancer cell line | DNA microarray analysis | [45] | Cholangiocarcinoma | Cancer cell line | RT-PCR, Western blot | [46] | Testicular seminomas | Cancer cell line and tumor tissue | Immunohistochemistry, Western blot | [47] | Breast cancer | Cancer cell line and tumor tissue | RT-PCR, Western blot, immunohistochemistry, and DNA microarray analysis | [48ā52] | Cervical cancer | Cancer cell line | Western blot | [50] | Prostate cancer | Cancer cell line | Western blot | [50] | Colorectal cancer | Cancer cell line and tumor tissue | Western blot, DNA microarray analysis, and immunohistochemistry | [53, 54] | Malignant peripheral nerve sheath tumors | Tumor tissue | DNA microarray analysis, immunohistochemistry | [55] | Lung adenocarcinoma | Tumor tissue | DNA microarray analysis, immunohistochemistry, immunofluorescence | [12, 56] | Renal cell carcinoma | Tumor tissue | DNA microarray analysis | [57] | Pancreatic ductal adenocarcinoma | Tumor tissue | Real-time PCR, immunohistochemistry | [58] | Multiple myeloma | Cancer cell line and tumor tissue | DNA microarray analysis | [12] | Myeloid leukemia | Tumor tissue | DNA microarray analysis | [12] | Mantle cell lymphoma | Tumor tissue | DNA microarray analysis | [12] | Mesothelioma | Tumor tissue | DNA microarray analysis | [12] | Head and neck squamous cell carcinoma | Tumor tissue | DNA microarray analysis | [12] | Bladder carcinoma | Tumor tissue | DNA microarray analysis | [12] | Glioblastoma | Tumor tissue | DNA microarray analysis | [12] | T cell acute lymphoblastic leukemia | Tumor tissue | DNA microarray analysis | [12] | Hepatocellular carcinoma | Tumor tissue | DNA microarray analysis | [12] | Melanoma | Tumor tissue | DNA microarray analysis | [12] | Ovarian adenocarcinoma | Tumor tissue | DNA microarray analysis | [12] |
|
|